PHARMACOLOGICAL EVALUATION OF THE ANTIINFLAMMATORY ACTIVITY OF A CITRUS BIOFLAVONOID, HESPERIDIN, AND THE ISOFLAVONOIDS, DUARTIN AND CLAUSSEQUINONE, IN RATS AND MICE

Pretreatment of rats with hesperidin (50 and 100 mg kg(-1), s.c.) reduced the paw oedema induced by carrageenan by 47 and 63%, respectively, within 5 h. The effect was equivalent to that produced by indomethacin (10 mg kg(-1), p.o.), although unrelated to the administered dose, particularly at high doses. At 100 mg kg(-1) hesperidin decreased the rat paw oedema induced by dextran by 33%, without influencing the histamine-induced paw oedema. Hesperidin also inhibited pleurisy induced by carrageenan, reducing the volume of exudate and the number of migrating leucocytes by 48 and 34%, respectively, of control values. Equal doses of duartin and claussequinone were ineffective in all the above tests. Pretreatment of mice with hesperidin (100 mg kg(-1), s.c.) reduced acetic acid-induced abdominal constriction by 50%, but did not affect the tail flick response. Hyperthermia induced by yeast in rats was slightly reduced by hesperidin. No lesions of the gastric mucosae were detected in rats pretreated with hesperidin. The results indicate that hesperidin obtained from citrus cultures may present a potential therapeutical use as a mild antiinflammatory agent, being also useful as a precursor of new flavonoids endowed with such activity.